1 Williams DR and Lees AJ. Progressive supranuclear palsy: clinicopathological concepts and diagnostic challenges.
Lancet Neurol. 2009;8(3):270–9.
2 Stamelou M, de Silva R, Arias-Carrión O, Boura E, Höllerhage M, Oertel WH, et al. Rational therapeutic approaches to progressive supranuclear palsy. Brain. 2010;133(Pt 6):1578–90.
3 Höglinger GU, Respondek G, Stamelou M, Kurz C, Josephs KA, Lang AE, et al. Clinical diagnosis of progressive supranuclear palsy: The movement disorder society criteria. Mov Disord. 2017;32(6):853–64.
4 Sonthalia N, Ray S. The Hummingbird sign: a diagnostic clue for Steele-Richardson-Olszweski syndrome. BMJ Case Rep. 2012.
5 Apetauerova D, Scala SA, Hamill RW, Simon DK, Pathak S, Ruthazer R, et al. CoQ10 in progressive supranuclear palsy: A randomized, placebo-controlled, double-blind trial. Neurol Neuroimmunol Neuroinflamm. 2016;3(5):e266.